Elusys Therapeutics is a private company focused on the development of antibody therapeutics for the treatment of infectious disease. For over 10 years, Elusys has been engaged in development of new therapies for the treatment of anthrax exposure following a natural or intentional release of anthrax spores.
The company’s management team has extensive experience in late stage biologic drug development and in securing and m...
Elusys Therapeutics is a private company focused on the development of antibody therapeutics for the treatment of infectious disease. For over 10 years, Elusys has been engaged in development of new therapies for the treatment of anthrax exposure following a natural or intentional release of anthrax spores.
The company’s management team has extensive experience in late stage biologic drug development and in securing and managing government contracts supporting drug development. Since 2002, Elusys has received over $240 million in development grants and contracts from the Biomedical Advanced Research and Development Authority (BARDA).
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.